Injection of pace: the insulin delivery devices market spikes

Novo Nordisk, Eli Lilly and Medtronic, with a combined market share of approximately 50%, dominate the global insulin delivery devices market.



Injection of pace: the insulin delivery devices market spikes

Novo Nordisk, Eli Lilly and Medtronic, with a combined market share of approximately 50%, dominate the global insulin delivery devices market.